Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Guggenheim Healthcare Talks Idea Forum and Oncology Day Transcript

Feb 13, 2020 / 02:00PM GMT
Release Date Price: $20.25 (+0.75%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

All right. Good morning. My name is Michael Schmidt from the Guggenheim research team. I'm one of the biotech analysts at the firm, and it is my great pleasure to welcome the first presenting company this morning, Exelixis. With us today, we have Michael Morrissey, President and Chief Executive Officer. Michael, welcome, and thanks for joining us.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Thanks, Michael. Great to here.

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

Before we get into Q&A, just give us a quick overview of where we stand today and what happened sort of over the last 6 months that got us to this point.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Quick overview? Okay. I'll need about 30 minutes for that. Yes. Anyway, I'll be making forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot